Cargando…

NET-Triggered NLRP3 Activation and IL18 Release Drive Oxaliplatin-Induced Peripheral Neuropathy

Oxaliplatin is an antineoplastic agent frequently used in the treatment of gastrointestinal tumors. However, it causes dose-limiting sensorimotor neuropathy, referred to as oxaliplatin-induced peripheral neuropathy (OIPN), for which there is no effective treatment. Here, we report that the elevation...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Tongtong, Hu, Liang, Hu, Fan, Li, Kun, Wang, Chao-Yu, Zong, Li-Juan, Zhao, Ya-Qian, Zhang, Xiaotao, Li, Yan, Yang, Yang, Wang, Yu, Jiang, Chun-Yi, Wu, Xuefeng, Liu, Wen-Tao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Association for Cancer Research 2022
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9716254/ https://www.ncbi.nlm.nih.gov/pubmed/36255412 http://dx.doi.org/10.1158/2326-6066.CIR-22-0197

Ejemplares similares

Platinum accumulation in oxaliplatin‐induced peripheral neuropathy
por: Wei, Guoli, et al.
Publicado: (2021)

Management of oxaliplatin-induced peripheral neuropathy
por: Saif, M Wasif, et al.
Publicado: (2005)

Oxaliplatin-Induced Neuropathy in Colorectal Cancer
por: Weickhardt, Andrew, et al.
Publicado: (2011)

Herbal Medicine AC591 Prevents Oxaliplatin-Induced Peripheral Neuropathy in Animal Model and Cancer Patients
por: Cheng, Xiaolan, et al.
Publicado: (2017)

Management of Oxaliplatin-Induced Peripheral Sensory Neuropathy
por: Cavaletti, Guido, et al.
Publicado: (2020)

Prevention of Oxaliplatin-Induced Peripheral Neuropathy: A Systematic Review and Meta-Analysis
por: Peng, Siyu, et al.
Publicado: (2022)

NLRP3/IL1β inflammasome associated with the aging bladder triggers bladder dysfunction in female rats
por: Chen, Lin, et al.
Publicado: (2019)

Targeting strategies for oxaliplatin-induced peripheral neuropathy: clinical syndrome, molecular basis, and drug development
por: Yang, Yang, et al.
Publicado: (2021)

Subjective and objective assessment of oxaliplatin-induced peripheral neuropathy
por: Yoshida, Yoichiro, et al.
Publicado: (2015)

Astragali radix: could it be an adjuvant for oxaliplatin-induced neuropathy?
por: Di Cesare Mannelli, Lorenzo, et al.
Publicado: (2017)

A Prospective Study of Chronic Oxaliplatin-Induced Neuropathy in Patients with Colon Cancer: Long-Term Outcomes and Predictors of Severe Oxaliplatin-Induced Neuropathy
por: Kim, Su-Hyun, et al.
Publicado: (2018)

OR11-004 - IL-1, IL-18 and cell death in NLRP3 driven disease
por: Broderick, L, et al.
Publicado: (2013)

Activation of NLRP3 inflammasome up-regulates TREM-1 expression in murine macrophages via HMGB1 and IL-18
por: Zhong, Wen-Jing, et al.
Publicado: (2020)

Promoting AMPK/SR-A1-mediated clearance of HMGB1 attenuates chemotherapy-induced peripheral neuropathy
por: Yang, Xing, et al.
Publicado: (2023)

Small extracellular vesicles ameliorate peripheral neuropathy and enhance chemotherapy of oxaliplatin on ovarian cancer
por: Zhang, Yi, et al.
Publicado: (2021)

Analgesic Effect of Melittin on Oxaliplatin-Induced Peripheral Neuropathy in Rats
por: Choi, Seunghwan, et al.
Publicado: (2019)

Acute Peripheral Motor Neuropathy Induced by Oxaliplatin-Correlated Hypokalaemia
por: Giampieri, Riccardo, et al.
Publicado: (2019)

Metformin protects from oxaliplatin induced peripheral neuropathy in rats
por: Martinez, N.W., et al.
Publicado: (2020)

Pathological Mechanisms and Preventive Strategies of Oxaliplatin-Induced Peripheral Neuropathy
por: Egashira, Nobuaki
Publicado: (2021)

“POLAR-izing” Findings From Trials of Neuroprotection for Oxaliplatin Neuropathy
por: Teng, Christina, et al.
Publicado: (2022)

Statins enhances antitumor effect of oxaliplatin in KRAS-mutated colorectal cancer cells and inhibits oxaliplatin-induced neuropathy
por: Tsubaki, Masanobu, et al.
Publicado: (2023)

The trigger for pancreatic disease: NLRP3 inflammasome
por: Liu, Tianming, et al.
Publicado: (2023)

Vincristine-induced peripheral neuropathy is driven by canonical NLRP3 activation and IL-1β release
por: Starobova, Hana, et al.
Publicado: (2021)

Distinct Licensing of IL-18 and IL-1β Secretion in Response to NLRP3 Inflammasome Activation
por: Schmidt, Rebecca L., et al.
Publicado: (2012)

Targeting lysosomal cysteine protease cathepsin S reveals immunomodulatory therapeutic strategy for oxaliplatin-induced peripheral neuropathy
por: Chen, Szu-Jung, et al.
Publicado: (2021)

Efferocytosis drives myeloid NLRP3 dependent inflammasome signaling secretion of IL-1β to promote tumor growth
por: Lang, Cara, et al.
Publicado: (2022)

Enhanced Expression of IL-18 and IL-18BP in Plasma of Patients with Eczema: Altered Expression of IL-18BP and IL-18 Receptor on Mast Cells
por: Hu, Yalin, et al.
Publicado: (2017)

NLRP3 inflammasome activation plays a carcinogenic role through effector cytokine IL-18 in lymphoma
por: Zhao, Xia, et al.
Publicado: (2017)

LPS-induced macrophage HMGB1-loaded extracellular vesicles trigger hepatocyte pyroptosis by activating the NLRP3 inflammasome
por: Wang, Guozhen, et al.
Publicado: (2021)

Elevated GRO-α and IL-18 in serum and brain implicate the NLRP3 inflammasome in frontotemporal dementia
por: Lok, Hiu Chuen, et al.
Publicado: (2023)

Effect of green tea extracts on oxaliplatin-induced peripheral neuropathy in rats
por: Lee, Jung Soo, et al.
Publicado: (2012)

Self-Management of Oxaliplatin-Related Peripheral Neuropathy in Colorectal Cancer Survivors
por: Tofthagen, Cindy, et al.
Publicado: (2013)

Efficacy of Goshajinkigan for Oxaliplatin-Induced Peripheral Neuropathy in Colorectal Cancer Patients
por: Yoshida, Naohisa, et al.
Publicado: (2013)

Exenatide Facilitates Recovery from Oxaliplatin-Induced Peripheral Neuropathy in Rats
por: Fujita, Shunsuke, et al.
Publicado: (2015)

Genetic polymorphisms of SCN9A are associated with oxaliplatin-induced neuropathy
por: Sereno, María, et al.
Publicado: (2017)

Amifostine protects from the peripheral sensory neuropathy induced by oxaliplatin in mice
por: Pereira, A.F., et al.
Publicado: (2020)

Neuroprotective effect of alogliptin on oxaliplatin-induced peripheral neuropathy in vivo and in vitro
por: Shigematsu, Nao, et al.
Publicado: (2020)

Oxaliplatin-induced peripheral neuropathy risk factors and management in Tunisian population
por: Zribi, Aref, et al.
Publicado: (2020)

Therapeutic Agents for Oxaliplatin-Induced Peripheral Neuropathy; Experimental and Clinical Evidence
por: Kawashiri, Takehiro, et al.
Publicado: (2021)

Impact of Dose, Sex, and Strain on Oxaliplatin-Induced Peripheral Neuropathy in Mice
por: Warncke, Urszula O., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_32ae9ndielfito72iltqc0uuon